Glen Harbor Capital Management LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
Glen Harbor Capital Management LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2019$1,544,000
+8.4%
12,240
+3.4%
0.03%
+6.7%
Q2 2019$1,424,000
+37.6%
11,8320.0%0.03%
+36.4%
Q1 2019$1,035,000
-9.4%
11,832
+3.6%
0.02%
-21.4%
Q4 2018$1,143,000
-12.7%
11,4240.0%0.03%
+7.7%
Q3 2018$1,309,000
+63.8%
11,424
+28.2%
0.03%
+52.9%
Q2 2018$799,000
+22.5%
8,9080.0%0.02%
+13.3%
Q1 2018$652,000
+26.1%
8,9080.0%0.02%
+25.0%
Q4 2017$517,000
+56.2%
8,908
+20.7%
0.01%
+50.0%
Q3 2017$331,000
+26.3%
7,378
+11.3%
0.01%
+33.3%
Q2 2017$262,000
+80.7%
6,630
+85.7%
0.01%
+50.0%
Q1 2017$145,000
+1.4%
3,5700.0%0.00%0.0%
Q4 2016$143,0003,5700.00%
Other shareholders
HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders